ValbonesiM., BruniR., De LuigiM.C.Therapeutic hemapheresis as of 2000. Vox Sang2000; 78(suppl 2): 51–6.
2.
MiiS., MoriA., SakataH.LDL apheresis for arteriosclerosis obliterans with occluded by pass graft: Change in prostacyclins and effect on ischemic syndrome. Angiology1998; 49: 175–80.
3.
MuroshimaJ., UekiY., MatsunagaY.Removal of low-density lipoprotein from plasma by absorption increases bradykinin and plasma nitric oxide levels in patients with peripheral artherosclerosis. Blood Coagul Fibrinolysis1998; 9: 725–32.
4.
KobayashiS., MoriyaH., NegishiK.LDL - apheresis up regulates VEGF and IGF-I in patients with ischemic limb. J Clin Apher2003; 18: 115–9.
5.
YehJ.H., ChinH.C.Coagulation abnormalities in serial double filtration plasmapheresis. J Clin Apher2001; 16: 139–42.
6.
RichterW.O., SchneidewindJ.M., RamlowW.Extracorporeal fibrinogen adsorption-efficacy, selectivity and safety in healthy subjects and patients with foot ulcers. Transfus Apher Sci2002; 26: 15–27.
7.
UllrichH., LacknerK., SchmitzG.Lepoprotein (a)-apheresis in the secondary prevention of coronary heart disease. Transfus Sci1996; 17: 511–7.
8.
HasegawaY., TargayaH., FujimotoS.Extracorporeal double filtration plasmapheresis in acute atherothrombotic brain infartion caused by major artery occlusive lesion. J Clin Apher2003; 18: 167–74.
9.
AydintugA.O., TokgözG., GürlerA.Antibodies to endothelial cells in patients with Behcet's disease. Clin Immunol Immunopathol1993; 67: 157–62.
10.
NomuraG., KogaN., YamagataY.Effective treatment of thrombo angiitis obliterans (Buerger's disease). In: OdaT., ed. Therapeutic plasmapheresis II.New York: FK Schattauer; 1982. p 561–3.
11.
KogaN., SasakiH., NishimuraT.Double filtration plasmapheresis: Clinical efficacy for peripheral vascular disorders (Buerger's disease and arteriosclerosis obliterans). In: OdaT., ShiokawaY., InoweN., eds. Proceedings of the 1st International Congress of the WAA: Therapeutic plasmapheresis (IV).Cleveland: ISAO Press; 1987. p 596–602.
12.
HeroldB.C., DavisA.T., ArroyaveC.M.Cryoprecipitates in Kavasaki Syndrome: Association with coronary artery aneurismis. Pediatr Infect Dis J1988; 7: 255–7.
13.
ShulmanS.T., RowelyA.H.Kawasaki disease ans IVIG treatment. Transfus Sci1992; 13: 309–15.
14.
LockwoodC.M., WorrlledgeS., CottonN.A.Reversal of infound splenic function in patients with nephritis or vasculitis (or both) by PE. N Engl J Med1979; 300: 524–30.
15.
BlétryO., BusselA., BadelonI.Intéret des échanges plasmatiques au cours des angeites necrosanites. Onze cas. Nouv Presse Med1982; 11: 2827–31.
16.
LhoteF., GuillevinL.Indications for plasma exchange in the treatment of plyarteritis nodosa, Churg-Strauss syndrome and other systemic vasculitides. Transfus Sci1996; 17: 211–23.
17.
ClutterbuckE.J., LockwoodC.M., PuseyC.D.Treatment of severe Churg-Strauss Syndrome with plasma exchange. Transfus Sci1986; 7: 117–21.
18.
CameroneG., GarelliS., ValbonesiM.Il trattamento mediante plasma-exchange di una paziente con grave porpora di Schonlein-Henoch. Minerva Med1982; 73: 1185–7.
19.
LewinskyR.J., BarrattT.M.IgA immune complexes in Henoch-Schonlein purpura. Lancet1979; 11: 1100–3.
20.
ItohK., MiharaA., OnonM.The histopathological evaluation of Henoch-Schonlein purpura nephritis treated by plasma exchange therapy. In: OdaT., ed. Therapeutic plasmapheresis II.Stuttgart, New York: FK Schattauer Verlag; 1982. p 203–5.
21.
Le Thi HuongD., WeehslerB., CabaneJ.Granulomatose de Wegener. Aspects cliniques, problèmes nasologique. Revue de la litterature à propos de 30 observations. Ann Med Interne1988; 139: 169–82.
22.
ThysellH., BygrenP., BengtssonU.Immunosuppression and the additive effects of PE in treatment of rapidly progressive glomerulonephritis. Acta Med Scand1982; 212: 107–14.
23.
ColeE., CattranD., MagilA.A prospective randomized trial of PE as additive therapy in idiophatic crescentic glomerulonephritis. Am J Kidney Dis1992; 20: 261–9.
24.
ValbonesiM., GarelliS., MosconiL.Plasma exchange in the management of a patient with diffuse necrotizing cutaneus vasculitis. Vox Sang1980; 39: 241–5.
25.
ValbonesiM., MosconiL., MontaniF.Cascade filtration clinical application in 26 patients with immune complexes and IgM mediated diseases. Int J Artif Organs1983; 6: 303–7.
26.
GianniniG., RuzzenentiM.R., ValbonesiM.Vasculite necrotizzante e scambio plasmatico: ma sono necessari i viaggi della speranza?Trasfusione del Sangue1998; 43: 119–20.
27.
CoelhoR.C., GalvaoM.L.Plasma exchange in rheumatoid vasculitis. Transfus Sci1992; 13: 119–23.
28.
RieuV., CohenP., AndreM.H.Characteristics and outcome of 49 patients with symptomatic cryoglobulinemia. Rheumatology (Oxford)2002; 41: 290–300.
29.
ValbonesiM., FlorioG., MontaniF.A method for the study of cryoglobulinemia solubilization curves at 37°C. preliminary studies and application to plasma exchange in cryoglobulinemia syndromes. Int J Artif Organs1983; 6: 87–90.
30.
ModarressiA., KuriyanM., HarveyG.Heat insoluble cryoglobulinemia associated with gangrene in multiple myeloma. J Clin Apher2003; 18: 190–3.
31.
NaritaH., OgataK., KikuchiI., InoueS.Extensive necrosis of the skin, muscle and bone was produced after prolonged cooling in a case of myeloma with cryoglobulinemia. Skin grafting was beneficial. Dermatologica1980; 160: 125–30.
32.
CirasinoL., BarbanoP.R.Images in clinical medicine. Gangrene and type I cryoglobulinemia in multiple myeloma. N Engl J Med1999; 341: 1582.
33.
SanmugarajahJ., HussainS., SchwartzJ.M., FriedmanS.Monoclonal cryoglobulinemia with estensive gangrene of all four extremities - a case report. Angiology2000; 51: 431–43.
34.
ValbonesiM.Plasmapheresis in the management of cryoglobulinemia. In: ValbonesiM., PinedaA.A., BiggsJ.C., eds. Therapeutic hemapherersis.Milano: Wichtig; 1986. p 89–96.
35.
BombardieriS., FerriC., PaleolongoG.Prolonged PE in the treatment of renal involvement in essential mixed cryoglobulinemia. Int J Artif Organs1982; 4: 47–50.
36.
McLeodB.C., SassettiR.J.Plasmapheresis with return of cryoglobulin-depleted autologous plasma (cryoglobulin-pheresis) in cryoglobulinemia. Blood1980; 55: 866–70.
37.
MalcheskyP.S., AsaumaY., ZawickiI.On-line separation of macromolecules by membrane filtration with cryogelation. In: Sieberth, ed. Plasma exchange-plasmapheresis-plasmaseparation.Stuttgart: Schattauer Verlag; 1980. p 133.
38.
SchneiderK.M.Plasmapheresis and immunoabsorption: Different techniques and their role in medical therapy. Kidney Int Suppl1998; 64: 561–5.
39.
O'ReillyM.J., TalposG., RobertsV.C.Controlled trial of plasma exchange in the treatment of Raynaud's syndrome. Br Med J1979; 1: 1113–5.
40.
CohenP., GuillevinL., GayrandM.Successful treatment of HIV related vasculitis with perpheral neuropathy with short-term steroids followed by the association of Zidovudine and plasmapheresis. Transfus Sci1993; 14: 383–9.
41.
GuillevinL., LhoteF., LeonA.Treatment of polyarteritis nodosa related to hepatitis B virus with short-term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol1993; 20: 289–98.
42.
Bourgeois-DroinC., SansonettiP., BusselA.Necroses cutanées étendues au cours d'une lèpre lépromateuse en poussèe réactionelle. Effect remarquable des échanges plasmatiques. Nouv Press Med1979; 8: 2357.
43.
PiepkornM., BrownC., ZoneJ.Auricular chonditris as a rheumatologic manifestations of Lucio's phenomenon: Clinical improvement after plasmapheresis. Ann Intern Med1983; 98: 49.
BjorvatnB., BjertnaesL., FadnesH.Meningococcal septicemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J1984; 288: 439–41.
46.
BrandtzaegP., SirnesK., FolslandB.Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicemia with DIC and fibrinolysis. Scand J Clin Lab Invest1985: 45 (suppl 178): S53–5.
47.
Van DeurenM., SantmanF., van DalenR.Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis1992; 15: 424–30.
48.
ChurchwellK.B., Mc ManusM.L., KentP.Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia. J Clin Apher1995; 10: 171–7.
49.
LaukfordK.V., GrindonH.J., LylesR.H.Indications for therapeutic plasma exchange at a University Hospital and a Regional Blood Center. J Clin Apher2000; 15: 242–8.
50.
TaraldsrudE., KvalheimJ.M., JørstadS.A survey of therapeutic hemapheresis in Norway year 2000. Transfus Apher Sci2003; 28: 135–41.
51.
StegmayrB., KorvichJ.M., NordaR.Is there a need for a national or a global apheresis registry?Transfus Apher Sci2003; 29: 179–85.
52.
De SilvestroG., MarsanP., RussoG.E.National survey of apheresis activity in Italy (2000). Transfus Apher Sci2004; 30: 61–71.
53.
PassalacquaS., StaffolaniE.Registro Italiano per l'aferesi terapeutica (Società Italiana di Nefrologia – SIN): primi 6 anni di attività. Atti IV Congresso Nazionale Chieti 2003.Cosenza: Editoriale Bios; 2003. p 209–18.
54.
KorachJ M., Petipas, PoironL.14 years of therapeutic plasma exchange in France. Transfus Apher Sci2001; 25: 73–7.
